NCT04636307View on ClinicalTrials.gov

Characterization of Retinal Disease Progression in Eyes With Non Proliferative Diabetic Retinopathy in Diabetes Type 2 Using Non-invasive Procedures (CHART)

Active, not recruitingOBSERVATIONAL
Enrollment

202

Participants

Timeline

Start Date

September 22, 2021

Primary Completion Date

March 21, 2023

Study Completion Date

May 22, 2025

Conditions
NPDR - Non Proliferative Diabetic RetinopathyDiabetes Mellitus, Type 2Retinal Disease
Interventions
OTHER

Biomarkers

To identify biomarkers obtained using non-invasive procedures that can predict disease progression and progression to sight-threatening stages of the disease and to characterize the retinal changes that occur in NPDR.

Trial Locations (5)

Unknown

CS042 - Department of Ophthalmology, University Hospital, CHU Dijon, Dijon

CS067- Department of Ophthalmology, University Vita Salute - Scientific Institute of San Raffael, Milan, Milan

CS063 - Excellence Eye Research Centre, University G. d'Annunzio of Chieti-Pescara, Pescara

CS020 - G. B. Bietti Eye Foundation - IRCCS, Roma

CS001 Centre for Clinical Trials - AIBILI, Coimbra

Sponsors
All Listed Sponsors
collaborator

European Vision Institute Clinical Research Network

NETWORK

lead

Association for Innovation and Biomedical Research on Light and Image

OTHER